CI to acquire U.S. wealth manager Radnor
The deal is the latest in a string of purchases that will bring the firm's U.S. assets to US$68 billion
- By: IE Staff
- June 28, 2021 June 28, 2021
- 12:29
The deal is the latest in a string of purchases that will bring the firm's U.S. assets to US$68 billion
Several changes take effect Monday
The prescribed rate on loans to family members remains set at 1%
Younger Canadians flocking to online investing represents a "generational shift," says RBC DI president and CEO
Szeto has moved his practice over from BMO Nesbitt Burns, where his team managed a $370-million book
The banks can resume paying out dividends to investors and buying back stock
Martin Dupras, president of ConFor Financiers, has been named chairman
The move will officially retire CI’s legacy boutique investment brands
Commercial mortgages account for the bulk of emissions financed by the credit union
Three firms set out to change their typical advisor force with new recruitment strategies
A private member's bill has beaten the odds, and the clock, in passing
Most investors aren't equipped to withstand the level of risk needed for outsized returns
Several banks will require documented proof or declaration of vaccination
The investment in Loop Capital allows the bank to expand its U.S. wealth management business
Many firms have new targets and strategies, but real change will take time
Programs aim to root out bias from customer service, but more work is needed
Powell's comments come as financial markets struggle to interpret the Fed’s recent moves
The absence of criminal charges against high-net-worth residents comes in an era of rising wealth inequality
Securities regulators ordered more than $42 million in restitution, compensation and disgorgement
For some, there is a feeling of distrust around government money
The brokerage's investment in technology is a key part of its new growth strategy
A long-term mindset offers competitive advantage
The amount of capital the banks must hold to cover unexpected losses will rise to 2.5%
The Liberals’ re-election prospects look promising thanks to the co-operation of Big Pharma